Patents by Inventor Peleg Rider

Peleg Rider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTI SUBUNIT PROTEIN MODULES, CELLS EXPRESSING SAME AND USES THEREOF
    Publication number: 20230340070
    Abstract: Multi subunit protein modules are provided. Accordingly, there is provided a multi subunit protein module comprising at least three cell membrane polypeptides each comprising an amino acid sequence of an Fc receptor common gamma chain (FcRgamma), said amino acid sequence is capable of transmitting an activating signal; wherein at least one but not all of said at least three polypeptides comprises an extracellular binding domain capable of binding a target that is presented on a cell surface of a target cell of an immune cell, such that upon binding of said extracellular binding domain to said target said activating signal is transmitted in an immune cell expressing said multi subunit protein module. Also provided are cells expressing the multi subunit protein modules and uses thereof.
    Type: Application
    Filed: December 21, 2022
    Publication date: October 26, 2023
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventors: Yaron CARMI, Peleg RIDER, Diana RASOULOUNIRIANA, Lior TAL
  • T CELL EXPRESSING AN FC GAMMA RECEPTOR AND METHODS OF USE THEREOF
    Publication number: 20210401893
    Abstract: A T cell expressing an FC gamma receptor is provided. Accordingly there is provided a T cell genetically engineered to express a first polypeptide comprising an amino acid sequence of an Fc receptor common ? chain (FcR?), said amino acid sequence is capable of transmitting an activating signal; and a second polypeptide comprising an extracellular ligand-binding domain of an Fc? receptor capable of binding an Fc ligand and an amino acid sequence capable of recruiting said first polypeptide such that upon binding of said Fc ligand to said extracellular ligand-binding domain of said Fc? receptor said activating signal is transmitted.
    Type: Application
    Filed: September 19, 2021
    Publication date: December 30, 2021
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventors: Yaron CARMI, Peleg RIDER, Diana RASOULOUNIRIANA
  • IL-1beta propeptide and IL-1Ra chimera and methods of using the same
    Patent number: 9895420
    Abstract: The present invention provides a chimera protein made of amino acid residues derived from IL-1beta propeptide and the IL-1Ra mature peptide and polynucleotides encoding the protein. The present invention also provides usages of the protein and the polynucleotides in pharmaceutical compositions that treat inflammation.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: February 20, 2018
    Assignees: B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN GURION UNIVERSITY, THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Eli Lewis, Peleg Rider, Charles A. Dinarello
  • IL-1beta-IL-1Ra CHIMERA AND METHODS OF USING THE SAME
    Publication number: 20160220641
    Abstract: The present invention provides a chimera protein made of amino acid residues derived from IL-1beta propeptide and the IL-1Ra mature peptide and polynucleotides encoding the protein. The present invention also provides usages of the protein and the polynucleotides in pharmaceutical compositions that treat inflammation.
    Type: Application
    Filed: June 5, 2014
    Publication date: August 4, 2016
    Applicants: B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD. (BE N-GURION UNIVERSITY), THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Eli Lewis, Peleg Rider, Charles A. Dinarello